These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29782195)

  • 1. Acute pancreatitis secondary to oral contraceptive-induced hypertriglyceridemia: a case report.
    Stumpf MAM; Kluthcovsky ACGC; Okamoto JM; Schrut GCA; Cajoeiro PO; Chacra APM; Bizeli R
    Gynecol Endocrinol; 2018 Nov; 34(11):930-932. PubMed ID: 29782195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertriglyceridemic Pancreatitis Caused by the Oral Contraceptive Agent Estrostep.
    Abraham M; Mitchell J; Simsovits D; Gasperino J
    J Intensive Care Med; 2015 Jul; 30(5):303-7. PubMed ID: 24671004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral contraceptive-induced pancreatitis in the hyperchylomicronemia syndrome].
    Schaefer JR; Steinmetz A; Dugi K; Ehlenz K; von Wichert P; Kaffarnik H
    Dtsch Med Wochenschr; 1995 Mar; 120(10):325-8. PubMed ID: 7875068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of a low-dose contraceptive--Femodene].
    Rachev E; Damianov L; Dukovski A; Katsarova M
    Akush Ginekol (Sofiia); 1995; 34(3):71-3. PubMed ID: 8787249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with an ethinyl estradiol-desogestrel oral contraceptive.
    Van Trappen Y; Duvivier P; Thiery M; Van Kets H; Defoort P; Parewijck W; Derom R; Kermans G; Schoofs P
    Arzneimittelforschung; 1989 Jun; 39(6):717-9. PubMed ID: 2528355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm].
    Milchev N; Terzhumanov R; Grozdanov G; Krumov G
    Akush Ginekol (Sofiia); 1992; 31(2):42-3. PubMed ID: 1342561
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with a gestodene containing oral contraceptive (femoden)].
    Gimes G; Valent S
    Acta Pharm Hung; 1998 Sep; 68(5):289-93. PubMed ID: 9805815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Deep venous thrombosis associated with the taking of oral contraceptives: the existence of Leiden factor V?].
    Gómez Sánchez-Biezma C; Pintor Holguín E; Buron Fernández MR; Sáez Noguero F
    Rev Clin Esp; 1997 Jun; 197(6):463-4. PubMed ID: 9304142
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What does the micropill bring?].
    Mall-Haefeli M
    Ther Umsch; 1986 May; 43(5):365-71. PubMed ID: 2941889
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased apolipoprotein AI production rate and redistribution of high-density lipoprotein size induced by estrogen plus progestin as oral contraceptive.
    Duvillard L; Dautin G; Florentin E; Jeannin A; Pais de Barros JP; Lagrost L; Petit JM; Gambert P; Vergès B
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4891-7. PubMed ID: 19858317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and panic disorder.
    Deci PA; Lydiard RB; Santos AB; Arana GW
    J Clin Psychiatry; 1992 May; 53(5):163-5. PubMed ID: 1592843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Back up contraception].
    Dacheva T
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():28-31. PubMed ID: 19504704
    [No Abstract]   [Full Text] [Related]  

  • 17. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
    Merz M; Kroll R; Lynen R; Bangerter K
    Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Were the severe adverse effects on several organs and the marked blood pressure increase caused by oral contraceptives?].
    Bergbrant A; Mattsson LA; Kutti J
    Lakartidningen; 1991 Feb; 88(8):621-2. PubMed ID: 1825862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe hypertriglyceridemia induced acute pancreatitis: a case report and review of the literature].
    Herrera Del Águila DD; Garavito Rentería J; Linarez Medina K; Lizarzaburu Rodríguez V
    Rev Gastroenterol Peru; 2015; 35(2):159-64. PubMed ID: 26228982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy and porphyria cutanea tarda.
    Rajka G
    Acta Derm Venereol; 1984; 64(5):444-5. PubMed ID: 6208730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.